Anthropic: The Biggest IPO Ever Could Also Be a Supply Shock.

September 09, 2026

Editor's note: Any and all references to time frames longer than one trading day are for purposes of market context only, and not recommendations of any holding time frame. Daily rebalancing ETFs are not meant to be held unmonitored for long periods. If you don't have the resources, time or inclination to constantly monitor and manage your positions, leveraged and inverse ETFs are not for you.

According to the latest estimates, Anthropic's implied valuation has roughly doubled in a matter of months. In late May, the company said it raised $65 billion at a $965 billion post-money valuation. ¹ Investors now discuss an October listing at $2 trillion or more.²

That repricing changes the nature of the story. At a $965 billion private valuation, this was already one of the largest fundraises on record. At a $2 trillion IPO valuation, it becomes a market event, and some are wondering where the money will come from.

The Numbers Have No Real Precedent

Until this year, the largest IPO ever was Saudi Aramco at $29.4 billion in 2019.³ Then SpaceX (Ticker: SPCX) priced 555.6 million shares at $135 in June, raising $75 billion, with an overallotment option that could lift the total to about $86 billion.⁴

Anthropic is reported to be targeting a raise that would match or exceed SpaceX’s.⁴ That would put two of the largest offerings in market history inside approximately four months.

A Buyer's Money Has to Come from Somewhere

Institutions typically don’t hold idle cash waiting for a mega-listing. Funding a position of this size usually means selling something else, and the likeliest candidates are the crowded mega-cap technology and AI names that have led the market for two years. A trader who wants exposure to Anthropic and already owns the AI trade is choosing between two versions of the same theme.

Index mechanics add a second layer. When the stock is added to major benchmarks, index funds become mechanical buyers, funded by proportional selling across existing holdings. That demand isn’t discretionary and doesn’t care about price.

The SpaceX Example and the October Calendar

The most useful precedent is three months old. SpaceX priced at $135, closed its first session at $160.95, and traded as high as $225.64 within days.⁵ By August 2, it hit an intraday low of $104.83 (below its offer price) before recovering into the $140s.⁵ A range of roughly $105 to $226 in under twelve weeks. A deal large enough to reprice a sector does not settle quietly.

October is also crowded for other market catalysts. Mega-cap earnings land late in the month, and the midterms follow in early November. A listing that pulls capital out of large-cap technology in the weeks before both would compress liquidity precisely when the market is trying to price two other outcomes.

The Number That Settles It

Everything above rests on an estimate. Anthropic has not confirmed a valuation, a date, or a size, and the $2 trillion figure comes from investors rather than the company. ²

The timeline is moving faster than the price. Anthropic is reportedly planning to release its IPO prospectus after Labor Day, targeting a public listing in late September or early October. ⁶ That would confirm the window this piece has been circling. It would not confirm the price.

The public S-1 changes that. It must be filed at least 15 days before a roadshow, and it will disclose the share count, price range, and float. These are the three inputs that determine how much capital this deal may pull out of the market. Until that document exists, the supply event is a projection.

To stay abreast of Anthropic's anticipated IPO and other market developments, you can register for Direxion Updates right to your email inbox. 

Direxion, a leading provider of ETFs for tactical traders, has filed with the U.S. Securities and Exchange Commission to launch the Direxion Daily Anthropic Bull 2X ETF (CLAU) and Direxion Daily Anthropic Bear 2X ETF (CLAD). Once effective, CLAU will seek daily investment results, before fees and expenses, of 200% of the daily performance of the common stock of Anthropic, and CLAD will seek daily investment results, before fees and expenses, of 200% of the inverse (-200%) of that performance. Both are expected to begin trading shortly after Anthropic completes its initial public offering, and its shares begin trading, subject to SEC effectiveness. For more information, go here.

* Definitions & Index Descriptions

To read the Pre-Effective Prospectus, click here.

The information in this Prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This Prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

Investing in the Funds involves a high degree of risk. Anthropic has not yet completed an initial public offering, and the Funds will not commence operations until Anthropic's common stock is publicly listed. As a newly public company, Anthropic may experience heightened volatility. Unlike traditional ETFs, or even other leveraged and/or inverse ETFs, these leveraged single-stock ETF tracks the price of a single stock rather than an index, eliminating the benefits of diversification. Leveraged ETFs pursue daily leveraged investment objectives, which means they are riskier than alternatives which do not use leverage. They seek daily goals and should not be expected to track the underlying stock’s performance over periods longer than one day. They are not suitable for all investors and should be utilized only by investors who understand leverage risk and who actively manage their investments. The Funds will lose money if the underlying stock’s performance is flat, and it is possible that the Funds will lose money even if the underlying stock’s performance increases, over a period longer than a single day. Investing in the Funds is not equivalent to investing directly in Anthropic.

Direxion Shares Risks – An investment in the ETFs involves risk, including the possible loss of principal. The ETFs are non-diversified and include risks associated with concentration that results from an ETF’s investments in a particular industry, sector or company, which can increase volatility. The leveraged and inverse ETFs utilize derivatives, such as futures contracts and swaps which are subject to market risks that may cause their price to fluctuate both intra-day and over time. The leveraged and inverse ETFs do not attempt to, and should not be expected to, provide returns which are a multiple of (or inverse of) the return of their respective index or underlying security for periods other than a single day. The leveraged and leveraged inverse ETFs may also be subject to leverage, correlation, daily compounding, market volatility and risks specific to an industry, sector or company. The ETFs are subject to certain risks, including imperfect index correlation and secondary market price variance, which may decrease performance. The ETFs may invest in a relatively small number of issuers and, as a result, be subject to greater risk of loss with respect to their portfolio securities than that of a fully diversified portfolio of securities. Due to the non-diversified nature of the ETFs, they may experience greater fluctuation in their net asset value as compared to other, more diversified investments. The non-leveraged ETFs may be appropriate for investors with a long-term investment time horizon, who primarily seek capital growth, and who are able to tolerate periods of prolonged price declines. Please read each ETF’s prospectus for a more complete description of the investment risks. There is no guarantee that an ETF will achieve its investment objective.